The -2 bp deletion in exon 6 of the ‘alpha 7-like’ nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit

Molecular Psychiatry

Volumn 7, Issue 9, 2002, Pages 1006-1011

  Raux, G ^a   Bonnet Brilhault, F ^a,b   Louchart, S ^b   Houy, E ^a,b   Gantier, R ^a   Levillain, D ^c   Allio, G ^b   Haouzir, S ^b   Petit, M ^a,b   Martinez, M ^a   Frebourg, T ^a   Thibaut, F ^a,b   Campion, Dominique ^a  

^a INSERM   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

^c CHS du Rouvray   (France)

Author keywords

Association; Endophenotype; Multiplex PCR; Nicotinic receptor; P50 sensory gating deficit; Schizophrenia

Indexed keywords

ALPHA-BUNGAROTOXIN RECEPTOR; BUNGAROTOXIN RECEPTOR; NICOTINIC RECEPTOR; GENOMIC DNA; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; EVOKED AUDITORY RESPONSE; EXON; FEMALE; GENE DELETION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; RISK FACTOR; SCHIZOPHRENIA; BASE PAIRING; CONTROLLED STUDY; DELETION MUTANT; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOME; HUMAN CELL; MAJOR CLINICAL STUDY; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; EVOKED POTENTIALS, AUDITORY; EXONS; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, NICOTINIC; RISK FACTORS; SCHIZOPHRENIA;

EID: 0036428860     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001140     Document Type: Article

References (13)

1. Freedman R, Adler LE, Waldo M. Gating of the auditory evoked potential in children and adults. Psychophysiology 1987; 24: 223-227.
2. Siegel C, Waldo M, Mizner G, Adler L, Freedman D. Deficit in sensory gating in schizophrenic patients and their relatives. Arch Gen Psych 1984; 41: 607-612.
3. Myles-Worsley M, Coon H, Byerley W, Waldo M, Young D, Freedman R. Developmental and genetic influences on the P50 sensory gating phenotype. Biol Psychiatry 1996; 39: 289-295.
4. Adler LE, Rose GM, Freedman R. Neurophysiologic studies of sensory gating in rats: Effects of amphetamine, phencyclidine and haloperidol. Biol Psychiatry 1986; 21: 787-798.
5. Luntz-Leybman V, Bickford PC, Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res 1992; 587: 130-136.
6. Freedman R, Hall M, Adler LE, Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 1995; 38: 22-23.
7. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 1997; 94: 587-592.
8. Gault J, Robinson M, Berger R, Drebing C, Logel J, Hopkins J et al. Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics 1998; 52: 173-185.
9. Weiland S, Bertrand D, Leonard S. Neuronal nicotinic acetylcholine receptors: From the gene to the disease. Behav Brain Res 2000; 113: 43-56.
10. Riley BP, Makoff A, Mogudi-Carter M, Jenkins T, Williamson R et al. Haplotype transmission disequilibrium and evidence for the linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families. Am J Med Genet 2000; 96: 196-201.
11. Charbonnier F, Raux G, Wang Q, Drouot N, Cordier F, Limacher JM et al. Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res 2000; 60: 2760-2763.
12. Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am J Psychiatry 2000; 15: 767-771.
13. Nagamoto HT, Adler LE, Waldo MC, Freedman R. Gating of auditory response in schizophrenics and normal controls: Effects of recording site and stimulation interval on the P50 wave. Schizophr Res 1991; 4: 31-41.